Halozyme Therapeutics
HALO
#2185
Rank
NZ$12.72 B
Marketcap
$99.99
Share price
1.06%
Change (1 day)
81.56%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: NZ$12.72 Billion

As of January 2025 Halozyme Therapeutics has a market cap of NZ$12.72 Billion. This makes Halozyme Therapeutics the world's 2185th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$12.72 B17.17%
2024NZ$10.85 B40.64%
2023NZ$7.72 B-36.29%
2022NZ$12.11 B46.21%
2021NZ$8.28 B3.58%
2020NZ$8.00 B122.33%
2019NZ$3.59 B14.02%
2018NZ$3.15 B-22.27%
2017NZ$4.06 B119.88%
2016NZ$1.84 B-43.08%
2015NZ$3.24 B109.56%
2014NZ$1.54 B-25.89%
2013NZ$2.08 B127.26%
2012NZ$0.91 B-27.24%
2011NZ$1.26 B22.37%
2010NZ$1.03 B39.35%
2009NZ$0.74 B-5.72%
2008NZ$0.78 B8.69%
2007NZ$0.72 B-7.93%
2006NZ$0.78 B389.59%
2005NZ$0.16 B5.75%
2004NZ$0.15 B

End of Day market cap according to different sources

On Jan 30th, 2025 the market cap of Halozyme Therapeutics was reported to be:

NZ$12.72 Billion
by Yahoo Finance info icon info icon
NZ$12.72 Billion
by CompaniesMarketCap info icon info icon
NZ$12.72 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$2.91 B-77.06%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.312 T 10,213.86%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$29.95 B 135.44%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$270.27 B 2,024.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$245.09 B 1,826.56%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$652.30 B 5,027.41%๐Ÿ‡บ๐Ÿ‡ธ USA